341 related articles for article (PubMed ID: 1488568)
1. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
Rammeloo RH; Luursema PB; Sips AP; Beumer HM; Wald FD; Cornelissen PJ
Respiration; 1992; 59(6):322-6. PubMed ID: 1488568
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
[TBL] [Abstract][Full Text] [Related]
3. Improved delivery of fenoterol plus ipratropium bromide using Respimat compared with a conventional metered dose inhaler.
Goldberg J; Freund E; Beckers B; Hinzmann R
Eur Respir J; 2001 Feb; 17(2):225-32. PubMed ID: 11334124
[TBL] [Abstract][Full Text] [Related]
4. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
5. Improved delivery of ipratropium bromide/fenoterol from Respimat Soft Mist Inhaler in patients with COPD.
Kilfeather SA; Ponitz HH; Beck E; Schmidt P; Lee A; Bowen I; Hesse Ch
Respir Med; 2004 May; 98(5):387-97. PubMed ID: 15139567
[TBL] [Abstract][Full Text] [Related]
6. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients.
Kunkel G; Magnussen H; Bergmann K; Juergens UR; de Mey C; Freund E; Hinzmann R; Beckers B
Respiration; 2000; 67(3):306-14. PubMed ID: 10867600
[TBL] [Abstract][Full Text] [Related]
7. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
[TBL] [Abstract][Full Text] [Related]
8. Studies of ipratropium bromide and fenoterol administered by metered-dose inhaler and aerosolized solution.
Marlin GE
Respiration; 1986; 50 Suppl 2():290-3. PubMed ID: 2951824
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
Huchon G; Hofbauer P; Cannizzaro G; Iacono P; Wald F
Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
[TBL] [Abstract][Full Text] [Related]
10. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease.
Guerin C; Chevre A; Dessirier P; Poncet T; Becquemin MH; Dequin PF; Le Guellec C; Jacques D; Fournier G
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1036-42. PubMed ID: 10194143
[TBL] [Abstract][Full Text] [Related]
11. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
[TBL] [Abstract][Full Text] [Related]
12. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
von Berg A; Jeena PM; Soemantri PA; Vertruyen A; Schmidt P; Gerken F; Razzouk H
Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
[TBL] [Abstract][Full Text] [Related]
14. Improved delivery of ipratropium bromide using Respimat (a new soft mist inhaler) compared with a conventional metered dose inhaler: cumulative dose response study in patients with COPD.
Iacono P; Velicitat P; Guemas E; Leclerc V; Thébault JJ
Respir Med; 2000 May; 94(5):490-5. PubMed ID: 10868713
[TBL] [Abstract][Full Text] [Related]
15. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
[TBL] [Abstract][Full Text] [Related]
16. A dose-response and duration of action assessment of a combined preparation of fenoterol and ipratropium bromide (Duovent).
Packe GE; Archer PS; Cayton RM
Postgrad Med J; 1984; 60 Suppl 1():18-22. PubMed ID: 6233546
[TBL] [Abstract][Full Text] [Related]
17. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
Brand P; Hederer B; Austen G; Dewberry H; Meyer T
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
[TBL] [Abstract][Full Text] [Related]
18. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
19. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
Kässner F; Hodder R; Bateman ED
Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
